Platelet-rich plasma (PRP) for vaginal health is an experimental treatment with limited, low-quality evidence. Small studies suggest possible benefits for some women with vaginal dryness, mild stress incontinence, sexual dysfunction or lichen sclerosus, but large, well-controlled trials are lacking. PRP should not replace proven treatments and is best considered only after a proper diagnosis and informed discussion.
What is platelet-rich plasma?
Platelet-rich plasma is a concentrate of platelets prepared from a sample of the patient's own blood. The blood is spun in a centrifuge to separate the platelet-rich layer, which is then injected or applied to the target tissue. Platelets contain growth factors involved in wound healing, blood vessel formation and tissue repair. The theory is that concentrating these factors can stimulate regeneration of tissues such as the vaginal wall, the vulvar skin or the tissues supporting the urethra.
PRP is used in sports medicine, dermatology, dentistry and hair restoration, with varying levels of supporting evidence. Its use in gynecology is more recent. Because it is prepared from a patient's own blood, it has sometimes been offered outside the regulatory pathways that apply to new drugs, and preparation methods differ widely between centers.
How is PRP used in gynecology?
PRP has been studied or promoted for several gynecologic and pelvic floor conditions:
- Genitourinary syndrome of menopause, including dryness and painful sex
- Vulvar lichen sclerosus, alongside or after topical steroid therapy
- Mild stress urinary incontinence, injected near the urethra
- Female sexual dysfunction, including arousal and orgasm difficulties
- Healing of perineal wounds, fistulas or scars
- Fertility-related uses such as thin endometrium or ovarian function, which are outside the scope of this article
What does the evidence actually show?
The research base is growing but remains weak overall.
- Most studies are small, often with fewer than one hundred participants.
- Many are observational or uncontrolled, so it is hard to separate the effect of PRP from placebo, natural improvement or other treatments.
- Follow-up is usually short, often a few months, so durability is unknown.
- Preparation methods, platelet concentrations, injection sites and number of sessions vary, making comparison difficult.
- A few randomized trials exist, particularly for lichen sclerosus, and results have been mixed; at least one randomized trial found PRP was not superior to placebo injections for lichen sclerosus symptoms.
In short, PRP may help some women, but there is not yet enough robust evidence to recommend it routinely for any vaginal or vulvar condition. Major gynecologic organizations have not endorsed it as a standard treatment.
It is also worth remembering that positive early studies do not always hold up. Many treatments that looked promising in small, open-label series have shown smaller or no benefits once tested against placebo in larger trials. Injection procedures in particular can produce strong placebo responses, because the experience of receiving a treatment itself influences how symptoms are perceived.
What are the limits of PRP?
Even where early results look encouraging, several practical limits remain.
- Benefits, if any, appear to be temporary, and repeat sessions are often suggested.
- There is no agreed standard protocol for preparation or dosing.
- PRP cannot correct structural problems such as prolapse, levator avulsion or a widened perineum.
- It does not replace estrogen when low hormone levels are the underlying cause of tissue thinning.
- Trademarked treatment names usually describe proprietary protocols rather than distinct, independently validated treatments.
Is PRP safe?
Because PRP is made from your own blood, the risk of allergic reaction or disease transmission is very low when sterile technique is used. Reported side effects are generally mild and short-lived, including pain at the injection site, bruising, swelling and spotting. Infection is possible with any injection. However, the absence of large trials means rare or long-term risks are not well characterized. The U.S. FDA's 2018 warning concerned energy-based devices rather than PRP, but its broader concern, that unproven vaginal treatments may be marketed beyond the evidence, applies here as well.
Who performs the procedure matters. Injections into the vulva, clitoral area or around the urethra require detailed anatomical knowledge, and the treating clinician should be able to recognize and manage complications as well as the underlying gynecologic condition.
Who might benefit from PRP?
PRP may be reasonable to discuss, ideally within a research setting or with a clinician who explains its experimental status, for women who:
- Have lichen sclerosus that remains symptomatic despite correctly used topical steroids, as an adjunct rather than a replacement
- Have genitourinary syndrome of menopause and cannot or prefer not to use hormonal treatment, after non-hormonal options have been tried
- Have mild stress incontinence and have completed supervised pelvic floor training but wish to avoid surgery, understanding the evidence is limited
- Have been fully assessed to exclude conditions that need other treatment
PRP is generally not suitable for women with active infection, certain blood or platelet disorders, active cancer in the treatment area, or those taking medications that impair platelet function, unless a specialist advises otherwise.
Questions to ask before considering PRP
- What is my diagnosis, and what are the proven first-line treatments for it?
- Have I tried those treatments correctly and for long enough?
- What studies support PRP for my specific condition, and how large were they?
- How is the PRP prepared, and how many sessions are recommended?
- How will success be measured, and what happens if there is no improvement?
- What side effects should I watch for, and who manages them?
Proven alternatives to consider first
For most women, established options should come first. Vaginal moisturizers and low-dose vaginal estrogen treat genitourinary syndrome of menopause effectively. High-potency topical steroids are the standard first-line therapy for lichen sclerosus. Supervised pelvic floor muscle training is first-line for stress incontinence, with bulking agents and slings available when needed. Sexual concerns benefit from a holistic assessment covering hormones, pain, medications, relationship factors and mental health.
Frequently asked questions
Is PRP approved for vaginal treatment?
Devices used to prepare PRP may be cleared for preparing blood products, but PRP injection for vaginal or vulvar conditions is not an established, approved indication. It should be presented as an emerging or experimental therapy.
How long do PRP results last?
There is not enough long-term data to say. Studies that report benefits typically follow women for months rather than years, and repeat treatments are often proposed.
Does PRP help with vaginal laxity?
Evidence for laxity is very limited. PRP cannot correct muscle injury or connective tissue stretch, which are common causes of laxity after childbirth.
Is PRP painful?
A local anesthetic cream or injection is usually used, so most women describe brief discomfort rather than severe pain. Some soreness, swelling or bruising for a few days afterwards is common.
Can PRP be combined with other treatments?
It is sometimes combined with laser or hyaluronic acid, but combination protocols are even less studied. Combining it with proven therapy, such as topical steroids for lichen sclerosus, is more defensible.
References
- American College of Obstetricians and Gynecologists. Committee Opinion No. 795: Elective Female Genital Cosmetic Surgery. 2020.
- U.S. Food and Drug Administration. Statement on efforts to safeguard women's health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for "vaginal rejuvenation." 2018.
- The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement. Menopause, 2020.
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 93: Diagnosis and Management of Vulvar Skin Disorders. 2008.
This article is for general education and does not replace an examination by a qualified gynecologist. Individual results vary, and every procedure carries risks.
